Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: a propensity score-matched retrospective cohort study

Pretreatment with oral contraceptives benefit POSEIDON group 1 low prognosis patients during GnRH-antagonist protocol: a propensity score-matched retrospective cohort study

Abstract Background Poor ovarian response (POR) is a challenging condition in assisted reproduction technology. Oral contraceptives (OCs) are commonly used to suppress gonadotropin hormone release in POR patients to synchronize the development of antral follicles before ovarian stimulation. Neverthe...

Full description

Saved in:
Bibliographic Details
Main Authors: Ning Wu, Xin Li, Cheng Zeng, Jing Shang, Xiuli Yang, Qing Xue
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Journal of Ovarian Research
Subjects:
Oral contraceptive
Poor ovarian response
POSEIDON criteria
Clinical outcomes
Pretreatment
Online Access:https://doi.org/10.1186/s13048-025-01613-6
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13048-025-01613-6

Similar Items